研究室業績2007-2012

2007

Serine protease Omi/HtrA2 targets WARTS kinase to control cell proliferation.

Kuninaka S, Iida SI, Hara T, Nomura M, Naoe H, Morisaki T, Nitta M, Arima Y, Mimori T, Yonehara S, Saya H.
Oncogene. 2007 Apr 12;26(17):2395-406. Epub 2006 Nov 20.

共同研究

2007

Visualizing the dynamics of p21(Waf1/Cip1) cyclin-dependent kinase inhibitor expression in living animals.

Ohtani N, Imamura Y, Yamakoshi K, Hirota F, Nakayama R, Kubo Y, Ishimaru N, Takahashi A, Hirao A, Shimizu T, Mann DJ, Saya H, Hayashi Y, Arase S, Matsumoto M, Kazuki N, Hara E.
Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15034-9.

The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?

Bronner C, Achour M, Arima Y, Chataigneau T, Saya H, Schini-Kerth VB.
Pharmacol Ther. 2007 Sep;115(3):419-34. (Review article)

Zoledronate-induced S phase arrest and apoptosis accompanied by DNA damage and activation of the ATM/Chk1/cdc25 pathway in human osteosarcoma cells.

Iguchi T, Miyakawa Y, Saito K, Nakabayashi C, Nakanishi M, Saya H, Ikeda Y, Kizaki M.
Int J Oncol. 2007 Aug;31(2):285-91.

ADAM-17 associated with CD44 cleavage and metastasis in oral squamous cell carcinoma.

Takamune Y, Ikebe T, Nagano O, Nakayama H, Ota K, Obayashi T, Saya H, Shinohara M.
Virchows Arch. 2007 Feb;450(2):169-77.

NDEL1 phosphorylation by Aurora-A kinase is essential for centrosomal maturation, separation, and TACC3 recruitment.

Mori D, Yano Y, Toyo-oka K, Yoshida N, Yamada M, Muramatsu M, Zhang D, Saya H, Toyoshima YY, Kinoshita K, Wynshaw-Boris A, Hirotsune S.
Mol Cell Biol. 2007 Jan;27(1):352-67.